メタボロミクスの世界市場－市場規模、セグメント、展望、収益予測：製品・サービス別、適応症別、用途別、地域別（2022年～2028年）

世界のメタボロミクスの市場規模は、予測期間（2022年～2028年）に12%のCAGRで成長し、2028年には約50億米ドルに達すると予測されています。がんや神経疾患、冠動脈疾患など生命を脅かす疾患の増加、政府および民間による業界への投資の急増、メタボロミクスと機械学習（ML）の組み合わせは、市場拡大の要因となっています。

当レポートでは、世界のメタボロミクス市場について調査分析し、主要な動向、競合情勢、市場分析など、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

• 世界のメタボロミクス市場の成長実績と予測のハイライト
• 市場動向、課題、競合のハイライト
• 市場収益シェアのハイライト：セグメント別

第2章 市場概要と成長に影響を与える主要な動向

• 世界のメタボロミクス市場分類
• 用途バリューチェーン
• 世界のメタボロミクス市場における主要企業のエコシステム
• 政府の規制と開発
• 市場に影響を与える主要な促進要因と課題
• COVID-19が世界のメタボロミクス市場に与える影響
• 世界メタボロミクス市場の成長実績（2017年～2021年）：セグメントタイプ別
• 製品・サービス別
• 適応症別
• 用途別
• 地域別
• 全世界メタボロミクス市場の実績と予測の成長（2017年～2028年）
• 重要ポイント

第3章 世界の市場セグメンテーション、成長実績、展望、予測：製品・サービス別

• 市場の定義－セグメンテーション：製品・サービス別
• 市場収益シェア、成長実績、展望、予測（2017年～2028年）：製品・サービス別
• メタボロミクス機器
• メタボロミクスバイオインフォマティクスのツールとサービス
• 市場セグメンテーションからの重要なポイント：製品・サービス別

第4章 世界の市場セグメンテーション、成長実績、展望、予測：適応症別

• 市場の定義－セグメンテーション：適応症別
• 市場収益シェア、成長実績、展望、予測（2017年～2028年）：適応症別
• がん
• 心血管障害
• 神経疾患
• 先天性代謝異常
• 代謝障害
• その他
• 市場セグメンテーションからの重要なポイント：適応症別

第5章 世界の市場セグメンテーション、成長実績、展望、予測：用途別

• 市場の定義－セグメンテーション：用途別
• 市場収益シェア、成長実績、展望、予測（2017年～2028年）：用途別
• バイオマーカーの発見
• 毒物学
• ニュートリゲノミクス
• 個別化医療
• 創薬
• 機能ゲノミクス
• その他
• 市場セグメンテーションからの重要なポイント：用途別

第6章 用途/競合分析－競合情勢

• 企業（競合企業）タイプと競合シェア
• 世界のメタボロミクス競合のポーターのファイブフォース分析
• 市場の成長に影響を与える世界メタボロミクスセクターの主な開発
• 世界のメタボロミクス市場における主要な競合の比較（2021年）
• 世界のメタボロミクス市場における主要な競合の比較（2021年）：製品・サービス範囲別
• 世界のメタボロミクス市場における主要な競合の比較（2021年）：適応症範囲別
• 世界のメタボロミクス市場における主要な競合の比較（2021年）：用途範囲別
• 世界のメタボロミクス市場における主要な競合の比較（2021年）：地域範囲別
• 競合情勢からの重要ポイント

第7章 主要な競合企業プロファイル（会社概要、主要な競合の強みと弱み）

• Agilent Technologies, Inc.
• Danaher
• Shimadzu Corporation
• Waters Corporation
• Bruker
• Human Metabolome Technologies Inc
• Thermo Fisher Scientific
• LECO Corporation
• Metabolon INC
• PerkinElmer Inc.

第8章 地域分析と主要地域市場の成長実績、展望、予測

• マクロ経済要因の主要地域比較
• 全世界市場収益シェア、成長実績、地域予測（2017年～2028年）：地域別
• 主要地域の市場分析、成長実績、展望、予測
• 北米－メタボロミクス市場分析
• 欧州－メタボロミクス市場分析
• アジア太平洋－メタボロミクス市場分析
• ラテンアメリカ、中東、アフリカ－メタボロミクス市場分析

第9章 用途専門家の意見/展望

• 市場の現在の状況と将来の展望に関する用途の専門家とCレベルのエグゼクティブからの注目すべき声明/引用

第10章 アナリストの推奨

• 特定された主要な機会と機会から得られる可能性のある戦略に関するアナリストの推奨事項

第11章 付録

• 調査手法－市場規模の推定、予測、および健全性チェックのアプローチ
• サンプルディスカッションガイド

免責事項

Market Overview

The scientific study of chemical processes, including metabolites, is known as metabolomics. Metabolomics is undoubtedly the careful study of the specific chemical traces that particular biological processes leave behind. The comprehensive measurement of all metabolites and low-molecular-weight compounds in biological material is the broad definition of the developing field of metabolomics. Metabolomics continues to show promise as a fundamental objective lens in the molecular microscope for precision medicine because it enables the profile of significantly more metabolites than are immediately covered by conventional clinical laboratory techniques.

According to Ken Research Analysis, the Global Metabolomics Market was valued at ~US$ 1.5 billion in 2017. The availability of government and private funding for metabolomics research has driven the global metabolomics market's rapid expansion. A significant emphasis is being placed on cutting-edge methods that can effectively detect and treat life-threatening diseases, such as cancer and cardiovascular disease, owing to the prevalence and mortality rate of such diseases.

It is estimated to be ~US$ 2.5 billion in 2022 and is expected to reach a market size of ~US$ 5 billion by 2028 growing at a CAGR of ~12% during 2022-2028.

Metabolomics offers a rising focus on innovative approaches with significant potential due to the rise in life-threatening diseases like cancer neurological conditions, and coronary heart disease, which has resulted in a surge in both government and private investments in the industry.

Another factor promoting metabolomics market expansion is the combination of metabolomics and machine learning (ML). Nuclear Magnetic Resonance (NMR) and Multiple sclerosis (MS) data can be accurately interpreted with the use of machine learning (ML), which also automates employment, and complex processes.

A variety of heterogeneous data is generated by metabolomics techniques, and interpreting such data can be difficult and complex. Any analytical method cannot be used to analyze the data due to the chemical diversity of small molecule metabolites. The prosperity of the market as a whole is being impeded by all of such factors.

The metabolomics market has a potential impact from COVID-19. As a result of the utilization of metabolomics in research to understand COVID-19 diseases.

Scope of the Report

The Global Metabolomics Market is segmented into By Products and Services, Indications, and Applications. In addition, the report also covers market size and forecasts for the four regions. The revenue used to size and forecast the market for each segment is US$ Billion

By Product and Services

Metabolomics Instrument

Metabolomics bioinformatics tools and services

By Indication

Cancer

Cardiovascular Disorders

Neurological Disorders

Inborn Errors of Metabolism

Metabolic Disorders

Others

By Application

Biomarker Discovery

Toxicology

Nutrigenomics

Personalized Medicine

Drug Discovery

Functional Genomics

Other

By Geography

North America (USA, Canada, and Mexico)

Europe (France, Italy, Germany, Spain, UK, and Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Australia, and Rest of Asia Pacific)

LAMEA (Latin America, Middle East, and Africa)

Key Players

Agilent Technologies, Inc.

Danaher.

Shimadzu Corporation

Waters Corporation

Bruker

Human Metabolome Technologies Inc

Thermo Fisher Scientific

LECO Corporation

Metabolon INC

PerkinElmer Inc.

Key Trends by Market Segment

By Product and Services - TheMetabolomics Instrument by Product and Services dominated the market in 2021, due to the extensive utilization of market products in research activities around the world in the disciplines of medicine, nutraceuticals, and metabolomics.

The growth is attributed to the rapid acceptance of metabolomics and smooth technological operations, which leads to increased workflow efficiency, precision, dependability, and data processing.

During the forecast period, factors such as the technical improvements in analytical instruments in terms of miniaturization, automation, and computerization, and the improvement of healthcare infrastructure in developing countries for effective illness detection and treatment are anticipated to drive the growth of the segment.

By Indication - The Cancer segment accounted for the highest market share in 2021, owing to the rise in cancer incidence around the globe and the expansion of oncological research projects.

According to World Health Organization (WHO), in February 2022 stated that Cancer is the leading cause of death throughout the world, accounting for nearly 10 million deaths in 2020, or nearly one in each six.

According to the American Cancer Society, in 2021, there will be an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States

By Application - Biomarker Discovery accounted for the highest market share in 2021 owing to the worldwide increase in the prevalence of chronic diseases such as Cancer, Chronic Obstructive Pulmonary Disease (COPD), and Arthritis.

The market's bigger contribution to the discovery of new biomarkers is also driven by extensive oncological research with a preference for the study of such markers and their application in the treatment of cancer.

Metabolic biomarkers are rapidly being utilized to assess patients' pathophysiological health conditions. Metabolomics has evolved in recent years into a crucial tool for identifying biomarkers as a result of major technological advancements.

By Geography: North Americaaccounted for the largest market share among all regions in 2021, owing to the presence of major Metabolomics studies and testing organizations like Agilent Technologies, Inc., Danaher., Waters Corporation, Bruker, and many more.

The region's substantial proportion can be linked to increasing biomedical research in the United States and rising preclinical operations by Contract research organizations (CROs) and pharmaceutical companies in the region.

According to the Centers for Disease Control and Prevention (CDC), in January 2022, 6 out of 10 adults in the United States have a chronic disease, and 4 out of 10 persons have more than one or two. The high prevalence of chronic diseases necessitates the development of novel, cutting-edge therapies, increasing the use of metabolomics and fostering business expansion.

Competitive Landscape

The Global Metabolomics Market is highly competitive with ~200 players which include globally diversified players, regional players as well as a large number of country-niche players each with their niche in Metabolomics research and testing. Large global players constitute ~20% of competitors, while country niche players represent the largest number of competitors. New drug discoveries are increasingly in demand. The demand for metabolomics is rising since it is used to test prospective biomarkers (certain cells, chemicals, genes, gene products, enzymes, or hormones) to assess the responsiveness of cancer therapy and enable early detection. The market is expanding as a result of strategic actions such as partnerships, collaborations, mergers, acquisitions, new product launches, and the rising demand for cutting-edge technologies. Some of the major players in the market include Agilent Technologies, Inc., Danaher, Shimadzu Corporation, Waters Corporation, Bruker, Human Metabolome Technologies Inc., Thermo Fisher Scientific, LECO Corporation, Metabolon INC, PerkinElmer Inc., and others.

Recent Developments Related to Major Players

In March 2020, Danaher Corporation announced that it had successfully acquired the Life Sciences section of General Electric Company's Biopharma business. The company will be a stand-alone operating company within Danaher's Life Sciences division and will be a part of Danaher under the name Cytiva.

In June 2021, Bruker Corporation announced the launch of two new Tim stop instruments: Next-gen timsTOF Pro 2 with Unprecedented Proteomic Depth and tims TOF SCP for Unbiased Single Cell 4D-Proteomics.

Conclusion

The Global Metabolomics Market is anticipated to grow significantly during the projected period (2022-2028) owing to the growing availability of government and corporate funding for metabolomics research, increasing R&D expenditure in the pharmaceutical and biopharmaceutical industry, and ongoing improvements in metabolomics technologies driving the expansion of the global metabolomics market during the anticipated period. Though the market is competitive with ~200 participants, country-niche players control the dominant share and regional players also hold a significant share.

Note:This is an On-Demand/Planned report, so the figures quoted here for a market size estimate, forecast, growth, segment share, and competitive landscape are based on initial findings and might vary slightly in the actual report. Also, any required customizations can be covered to the best feasible extent for Pre-booking clients, and the report delivered within a maximum of two working weeks.

Key Topics Covered in the Report

Snapshot of Metabolomics Market

Industry Value Chain and Ecosystem Analysis

Market size and Segmentation of the Metabolomics Market

Historic Growth of the Overall Metabolomics Market and Segments

Competition Scenario of the Market and Key Developments of Competitors

Porter's 5 Forces Analysis of the Metabolomics Market Industry

Overview, Product and Services Offerings, and Strengths & Weaknesses of Key Competitors

COVID-19 Impact on the Overall Metabolomics Market

Future Market Forecast and Growth Rates of the Total Metabolomics Market and by Segments

Market Size of Segments with Historical CAGR and Future Forecasts

Analysis of the Metabolomics Market in Global Regions

Major Metabolomics Type/Supply and Consumption/Demand Hubs in the Region

Region-wise Historic and Future Market Growth Rates of the Total Market and Segments

Overview of Notable Emerging Competitor Companies within the Region

Notable Key Players Mentioned in the Report

Agilent Technologies, Inc.

Danaher

Shimadzu Corporation

Waters Corporation

Bruker

Human Metabolome Technologies Inc

Thermo Fisher Scientific

LECO Corporation

Metabolon INC

PerkinElmer Inc.

Notable Emerging Companies Mentioned in the Report

Million Marker

Prometheus Metabolomics

Afekta Technologies Ltd.

Adapsyn Bioscience Inc.

QuLab Medical Ltd

Key Target Audience - Organizations and Entities Who Can be benefited by Subscribing This Report

Manufacturers of Metabolomics

Distributors, Suppliers, and Sales Channels

Emerging and Startup Companies in Metabolomics

Metabolomics Manufacturers

Market research and consulting firms

Organizations, forums, and alliances related to Metabolomics

Metabolomics Testers

Global Metabolomics manufacturers, suppliers, distributors, and other stakeholders

Associations, organizations, forums, and alliances related to Metabolomics

Government bodies such as regulating authorities and policymakers

Time Period Captured in the Report

Historical Period: 2017-2021

Forecast Period: 2022E-2028F

Frequently Asked Questions

What is the Study Period of this Market Report?

The Global Metabolomics Market is covered from 2017-2028 in this report, which includes a forecast for the period 2022-2028.

What is the Future Growth Rate of the Global Metabolomics Market?

The Global Metabolomics Market is expected to witness a CAGR of ~12% over the next six years.

What are the Key Factors Driving the Global Metabolomics Market?

The rise in government and private organization financing for technical research, as well as the expansion of key players' partnerships and collaborations for the improvement of its product portfolio, are expected to be the primary driver of this market.

Which is the Largest Product and Services Segment within the Global Metabolomics Market?

The metabolomics instrument segment held the largest share of the global metabolomics market in 2021.

Who are the Key Players in the Global Metabolomics Market?

Agilent Technologies, Inc., Danaher, Shimadzu Corporation, Waters Corporation, Bruker, Human Metabolome Technologies Inc, Thermo Fisher Scientific, LECO Corporation, Metabolon INC, PerkinElmer Inc., and others are the major companies operating in the Global Metabolomics Market.

Table Of Contents

Scope

1. Executive Summary

• 1.1 Highlights of Global Metabolomics Market Historic Growth & Forecast
• 1.2 Highlights of Market Trends, Challenges, and Competition
• 1.3 Highlights of Market Revenue Share by Segments

2. Market Overview and Key Trends Impacting Growth

• 2.1 Global Metabolomics Market Taxonomy
• 2.2 Application Value Chain
• 2.3 The Ecosystem of Major Entities in the Global Metabolomics Market
• 2.4 Government Regulations & Developments
• 2.5 Key Growth Drivers & Challenges Impacting the Market
• 2.6 COVID-19 Impact on Global Metabolomics Market
• 2.7 Total Global Metabolomics Market Historic Growth by Segment Type, 2017-2021

2.7.1 By Product and Services

2.7.2 By Indication

2.7.3 By Application

2.7.4 By Regions

• 2.8 Total Global Metabolomics Market Historic & Forecast Growth, 2017-2028
• 2.9 Key Takeaways

3. Total Global - Market Segmentation By Product and Services, Historic Growth, Outlook & Forecasts

• 3.1 Market Definition - Segmentation By Product and Services
• 3.2 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Product and Services, 2017-2028

3.2.1 Metabolomics Instrument

3.2.2 Metabolomics Bioinformatics Tools and Services

• 3.3 Key Takeaways from Market Segmentation By Product and Services

4. Total Global - Market Segmentation by Indication Type, Historic Growth, Outlook & Forecasts

• 4.1 Market Definition - Segmentation by Indication Type
• 4.2 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Indication Type, 2017-2028

4.2.1 Cancer

4.2.2 Cardiovascular Disorders

4.2.3 Neurological Disorders

4.2.4 Inborn Errors of Metabolism

4.2.5 Metabolic Disorders

4.2.6 Others

• 4.3 Key Takeaways from Market Segmentation by Indication Type

5. Total Global - Market Segmentation by Application, Historic Growth, Outlook & Forecasts

• 5.1 Market Definition - Segmentation by Application
• 5.2 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Application, 2017-2028

5.2.1 Biomarker Discovery

5.2.2 Toxicology

5.2.3 Nutrigenomics

5.2.4 Personalized Medicine

5.2.5 Drug Discovery

5.2.6 Functional Genomics

5.2.7 Other

• 5.3 Key Takeaways from Market Segmentation by Application

6. Application / Competition Analysis - Competitive Landscape

• 6.1 Types of Players (Competitors) & Share of Competition
• 6.2 Porter's 5 Forces Analysis of Global Metabolomics Competitors
• 6.3 Key Developments in the Global Metabolomics Sector Impacting Market Growth
• 6.4 Comparison of Leading Competitors within the Global Metabolomics Market, 2021
• 6.5 Comparison of Leading Competitors within the Global Metabolomics Market by Coverage of Product and Services, 2021
• 6.6 Comparison of Leading Competitors within the Global Metabolomics Market by Coverage of Indication Type, 2021
• 6.7 Comparison of Leading Competitors within the Global Metabolomics Market by Coverage of Application, 2021
• 6.8 Comparison of Leading Competitors within the Global Metabolomics Market by Coverage of Regions, 2021
• 6.9 Key Takeaways from Competitive Landscape

7. Key Competitor Profiles (Company Overview, Strengths & Weakness of Key Competitors)

• 7.1 Agilent Technologies, Inc.
• 7.2 Danaher
• 7.3 Shimadzu Corporation
• 7.4 Waters Corporation
• 7.5 Bruker
• 7.6 Human Metabolome Technologies Inc
• 7.7 Thermo Fisher Scientific
• 7.8 LECO Corporation
• 7.9 Metabolon INC
• 7.10 PerkinElmer Inc.

8. Geographic Analysis & Major Region Market Historic Growth, Outlook, and Forecasts

• 8.1 Major Region Comparison of Macroeconomic Factors
• 8.2 Total Global- Market Revenue Share, Historic Growth, Outlook and Forecasts by Geography, 2017-2028
• 8.3 Major Region Market Analysis, Historic Growth, Outlook & Forecasts
• 8.4 North America - Metabolomics Market Analysis

8.4.1 Major Production and Consumption Hubs in North America

8.4.2 Notable Emerging Metabolomics Companies in North America

8.4.3 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Product and Services, 2017-2028

8.4.4 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Indication Type, 2017-2028

8.4.5 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Application, 2017-2028

8.4.6 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Major Countries, 2017-2028

USA

Canada

Mexico

• 8.5 Europe - Metabolomics Market Analysis

8.5.1 Major Production and Consumption Hubs in Europe

8.5.2 Notable Emerging Metabolomics Companies in Europe

8.5.3 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Product and Services, 2017-2028

8.5.4 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Indication Type, 2017-2028

8.5.5 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Application, 2017-2028

8.5.6 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Major Countries, 2017-2028

Germany

UK

France

Spain

Italy

Rest of Europe

• 8.6 Asia-Pacific - Metabolomics Market Analysis

8.6.1 Major Production and Consumption Hubs in Asia-Pacific

8.6.2 Notable Emerging Metabolomics Companies in Asia-Pacific

8.6.3 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Product and Services, 2017-2028

8.6.4 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Indication Type, 2017-2028

8.6.5 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Application, 2017-2028

8.6.6 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Major Countries, 2017-2028

China

Japan

South Korea

India

Australia

Rest of Asia-Pacific

• 8.7 LAMEA - Metabolomics Market Analysis

8.7.1 Major Production and Consumption Hubs in LAMEA

8.7.2 Notable Emerging Metabolomics Companies in LAMEA

8.7.3 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Product and Services, 2017-2028

8.7.4 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Indication Type, 2017-2028

8.7.5 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Application, 2017-2028

8.7.6 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Major Sub-regions, 2017-2028

Latin America

Middle East

Africa

9. Application Expert's Opinions/Perspectives

• 9.1 Notable Statements/Quotes from Application Experts and C-Level Executives on Current Status and Future Outlook of the Market

10. Analyst Recommendation

• 10.1 Analyst Recommendations on Identified Major Opportunities and Potential Strategies to Gain from Opportunities

11. Appendix

• 11.1 Research Methodology - Market Size Estimation, Forecast, and Sanity Check Approach
• 11.2 Sample Discussion Guide

Disclaimer